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Abstract
Background: Actinobacillus pleuropneumoniae, the causative agent of porcine contagious pleuropneumonia, is an important
pathogen of swine throughout the world. It must rapidly overcome the innate pulmonary immune defenses of the pig to
cause disease. To better understand this process, the objective of this study was to identify genes that are differentially
expressed in a medium that mimics the lung environment early in the infection process.
Methods and Principal Findings: Since bronchoalveolar lavage fluid (BALF) contains innate immune and other components
found in the lungs, we examined gene expression of a virulent serovar 1 strain of A. pleuropneumoniae after a 30 min
exposure to BALF, using DNA microarrays and real-time PCR. The functional classes of genes found to be up-regulated most
often in BALF were those encoding proteins involved in energy metabolism, especially anaerobic metabolism, and in cell
envelope, DNA, and protein biosynthesis. Transcription of a number of known virulence genes including apxIVA and the
gene for SapF, a protein which is involved in resistance to antimicrobial peptides, was also up-regulated in BALF. Seventy-
nine percent of the genes that were up-regulated in BALF encoded a known protein product, and of these, 44% had been
reported to be either expressed in vivo and/or involved in virulence.
Conclusions: The results of this study suggest that in early stages of infection, A. pleuropneumoniae may modulate
expression of genes involved in anaerobic energy generation and in the synthesis of proteins involved in cell wall
biogenesis, as well as established virulence factors. Given that many of these genes are thought to be expressed in vivo or
involved in virulence, incubation in BALF appears, at least partially, to simulate in vivo conditions and may provide a useful
medium for the discovery of novel vaccine or therapeutic targets.
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Introduction
Actinobacillus pleuropneumoniae is a species-specific swine pathogen
that causes a necrotizing, fibrinohaemorrhagic pneumonia with
pleurisy [1]. Depending upon the immune status of the animal,
disease can range in severity from peracute to chronic [2,3].
Although a protective immune response is usually acquired
through the adaptive immune system following acute infection,
vaccines offer only partial protection against this organism.
The lungs, which are the primary site of infection by A.
pleuropneumoniae, have a large surface area that is directly in contact
with the external environment. There are no published data for
swine, but in the human lung, there is an average of 480 million
alveoli [4] with an area of 120 to 140 m
2 [5]. The lungs are
protected by both innate and adaptive immune systems. Two
major components are involved in the innate immune system: a
cellular component comprised of leukocytes as well as airway and
alveolar epithelial cells, and a humoral component which includes
surfactant lipids and proteins, collectins, defensins, cathelicidins,
lysozyme, and lactoferrin [6]. Most of these innate immune
components reside in a thin layer of fluid lining the lung epithelial
cell layer and some have been shown to directly kill bacteria such
as Escherichia coli and Pseudomonas aeruginosa [7–9]. Inhaled particles,
including pathogens, first encounter the resident immune system
in this fluid layer, which forms the first line of defense [10,11].
Little work has been done to examine bacterial gene expression in
BALF, but in a recent study Schwab et al. [12] found that
Myobacterium tuberculosis genes encoding proteins which enabled the
organism to use surfactant lipids as a substrate and those for
synthesis of phthiolocerol dimycocerosate (PDIM), a protective cell
wall component, were up-regulated in the presence of a whole
lung surfactant preparation.
A. pleuropneumoniae is capable of overcoming innate pulmonary
immune mechanisms of the pig. It can rapidly multiply and spread
in naive herds, with some pigs dying within 24 h of infection
without showing any clinical signs. Several virulence factors have
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factors for colonization, nutrient acquisition, immune evasion and
tissue destruction have all been implicated in the disease process
[13,14]. Although some aspects of pathogenesis can be explained
by the production of tissue-damaging RTX toxins and the ability
of the pathogen to acquire nutrients such as iron in the host,
factors involved in bacterial survival and rapid multiplication in
the host are largely unknown.
To identify genes that may be involved in survival and
pathogenesis of A. pleuropneumoniae in the host we used porcine
bronchoalveolar fluid as a medium to simulate, in part, the lung
environment. By analogy with other species, BALF collected from
swine likely contains plasma proteins and proteins with unknown
functions [15] as well as proteins with diverse functions including
anti-oxidation, lipid-metabolism, and tissue repair and prolifera-
tion in addition to innate immune components and dissolved
minerals. Because BALF contains components that perform
diverse functions in the lungs, A. pleuropneumoniae gene expression
in this fluid could mimic gene expression in the host. Therefore,
the objective of this study was to identify A. pleuropneumoniae genes
that are differentially expressed in BALF to better understand
survival and pathogenesis of this important swine pathogen early
in the disease process.
Results and Discussion
Differential gene expression in BALF
The survival of A. pleuropneumoniae CM5 was assessed in BALF
before carrying out experiments to identify differentially expressed
genes since this fluid contains many antibacterial substances
[6,16]. No significant decrease was observed in A. pleuropneumoniae
CM5 cell numbers following incubation for 30 min in BALF,
while 70% of the E. coli DH5a cells were killed at this time.
Genes that were differentially expressed by A. pleuropneumoniae
after 30 min of incubation in BALF were identified with DNA
microarrays by hybridization of Cy3-labeled cDNA from the
BALF-incubated bacteria (target sample) and Cy5-labelled cDNA
from the BHI-incubated bacteria (reference sample). One hundred
and fifty-six genes were differentially expressed in BALF at a false
discovery rate (FDR) of 1.07%; 52 genes were down-regulated
while 104 were up-regulated. Forty-one (26%) of these genes
encode hypothetical proteins (Table 1).
Differential expression of selected genes representing various
biological functional classes of interest was confirmed by real-time
PCR analysis. Although fold change in gene expression measured
by real-time PCR was generally higher, there was a good
correlation between the two data sets, and no genes that were
deemed up-regulated with the microarrays were demonstrated to
be down-regulated by qRT-PCR, and vice-versa (Table 2). The
reason why the three nqr genes tested appeared to be overesti-
mated in the microarray analysis is not clear, but these slightly
divergent results were not likely due to dynamic range or % G+C
considerations.
The genes found to be most frequently up-regulated in BALF
were those encoding proteins involved in energy metabolism and
in cell envelope, DNA, and protein biosynthesis (Table S1). Genes
encoding proteins for co-factor biosynthesis, toxin production and
secretion and trafficking of ions and biomolecules were also up-
regulated while genes encoding proteins involved in protein
folding and stabilization, nucleotide biosynthesis, and mobile
elements were down-regulated. Representative genes belonging to
these functional classes are described below.
Modulation of gene expression for enhanced protein
synthesis and energy generation in BALF
Incubation of A. pleuropneumoniae CM5 in BALF for 30 min
resulted in increased expression of genes encoding 30S and 50S
ribosomal subunit proteins and tRNA modification enzymes
(Table S1). Such up-regulation of ribosomal genes could play a
role in synthesis of the proteins described below.
Genes encoding proteins involved in energy metabolism were
also up-regulated in BALF, with some showing an increase of
more than 6-fold. Most of these genes encoded enzymes involved
in anaerobic respiration, including those that were part of the
dimethyl sulfoxide reductase (dms) operon), periplasmic nitrate
reductase (nap) operon, nitrite reductase (nrf) operon and a primary
dehydrogenase, hydrogenase 2 (hya) operon (Table S1). Dimethyl
Table 1. Functional classes of differentially expressed genes.
Functional class No. up-regulated No. down-regulated Total differentially expressed genes
Protein biosynthesis 16 1 17
Amino acid biosynthesis 0 9 9
Cofactor biosynthesis (heme and vitamins) 6 0 6
Nucleotide biosynthesis 0 3 3
Lipid biosynthesis 1 0 1
Cell envelope biosynthesis 11 0 11
Detoxification and toxin production 5 1 6
DNA metabolism 8 0
Energy metabolism 22 4 26
Protein folding and stabilization 0 4 4
Transcriptional regulators 0 3 3
Secretion and trafficking 13 5 18
Transposon functions 0 3 3
Unclassified and unknowns 22 19 41
Total 104 52 157
doi:10.1371/journal.pone.0006139.t001
Gene Expression in BALF
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dimethyl sulfoxide and other substrates; the periplasmic-nitrate
and nitrite reductases are involved in transfer of electrons to
nitrate and nitrite respectively [17]. Hydrogenase 2, a primary
dehydrogenase, uses the hydrogen produced by formate hydrogen
lyase from formate as a substrate [18] for energy production
[19,20]. A putative formate transporter, focA, was also up-
regulated in BALF.
Previous studies have shown that A. pleuropneumoniae up-regulates
transcription of genes encoding enzymes involved in anaerobic
metabolism in porcine lungs and lung washings [21–23]. A.
pleuropneumoniae recovered from BALF following infection have
increased expression of hydrogenase 2 [21], aspartate ammonia
lyase (Asp) [24] and DMSO reductase [25], with DMSO reductase
levels being elevated in cells recovered from both acute and
chronic infections [22,23].
The components present in BALF that could lead to up-
regulation of anaerobic energy-metabolism genes in A. pleuropneu-
moniae are largely unknown; however, glutathione in the airway
epithelium might be an activator of HlyX, which is the A.
pleuropneumoniae equivalent of FNR in E. coli [26]. For example, it
has been reported HlyX up-regulates DMSO reductase (dms) and
aspartate ammonia lyase (asp), which breaks down aspartate to
fumarate and ammonia. Fumarate is used as an electron acceptor
under anaerobic conditions in A. pleuropneumoniae [27–30]. The fact
that a significant change of expression of hlyX was not observed
may be because differences in the level of expression of this gene
tend to be small. Moreover, like fnr, regulation of the hlyX gene
product is likely affected by a multitude of factors including protein
stability, growth phase and nutrient availability [31,32].
Up-regulation of the genes encoding the periplasmic nitrate
(Nap) reductase in BALF suggests a role for nitrate metabolism in
A. pleuropneumoniae energy production in the host. Nap uses nitrate
as an electron acceptor. As nitrate has a higher redox potential
than most other electron acceptors under anaerobic conditions
[17,33] it is a preferred electron acceptor. Nitrate is formed from
nitric oxide in the animal and is present in various body fluids [34–
37] where it can serve as a cue for the up-regulation of nitrate-
responsive genes in A. pleuropneumoniae. Nap has a higher affinity for
nitrate than membrane-bound nitrate reductase (Nar) [38], and it
can be used for nitrate utilization in body fluids with low nitrate
concentrations such as are found in the respiratory tract.
Nitrite reductase (Nrf) is another nitrate metabolism-related
enzyme whose genes were up-regulated in BALF. This enzyme
converts nitrite, a potential bacterial cell-damaging substance
produced by nitrate reductase, to ammonia. Nrf can also convert
nitric oxide to ammonium [39], thus inactivating a key defense
molecule of the host.
Given that A. pleuropneumoniae is a host-associated pathogen
which resides in oxygen-deprived environments in both the acute
and carrier states of the disease, the major production of energy is
likely through anaerobic metabolism. The absence of three main
TCA-cycle enzymes (citrate synthase, aconitase and isocitrate
dehydrogenase) in the genomes of serotype 3 and serotype 5 A.
pleuropneumoniae again points to the importance of anaerobic
metabolism in the survival of this organism [40]. In addition,
many upper respiratory tract pathogens including Haemophilus
influenzae, Pseudomonas aeruginosa, Pasteurella multocida, Neisseria
meningitidis, carry genes for anaerobic energy generation, consistent
with the notion that anaerobic metabolism might have an
important role in the survival and virulence of bacterial pathogens
in the respiratory tract.
Some of the genes encoding enzymes involved in anaerobic
energy production in A. pleuropneumoniae have been shown to be
essential for virulence. For example, knockout mutants of hlyX are
unable to survive in lung epithelium, sequestered lungs or tonsils
[29]; dmsA mutants are attenuated in acute disease [25]; and asp
mutants cause less severe lung lesions than the wild type organism
[24]. Similarly, in Bordetella pertussis, another respiratory tract
pathogen, the FNR homolog, Btr [41] is essential for survival of
this pathogen in mice [42].
The role of the nitrate-inducible energy metabolism genes, nap
and nrf, is unknown in A. pleuropneumoniae. Nitrate metabolism has,
however, been shown to be essential for the entry and replication
of Salmonella Typhi in epithelial cells [43] and for the survival and
virulence of Mycobacterium bovis in mice [44,45].
In addition to the genes encoding enzymes of energy
metabolism discussed above, the transcription of Na
+ -translocat-
ing NADH-quinone reductase (NQR) was also enhanced in BALF
(Table 3 and S1). NQR is a primary Na
+ pump that translocates
Na
+ ions outside the cytoplasmic membrane to generate a sodium
motive force, instead of a proton motive force, for energy
production [46,47]. The NQR enzyme is a complex of six
subunits encoded by the nqrABCDEF operon [48,49]; all six genes
Table 2. Verification of microarray data by real-time PCR.
Gene Gene name Fold change by real-time PCR Fold change by microarray
dmsA Anaerobic dimethyl sulfoxide reductase chain A precursor 17.9066.52 5.74
dmsB Anaerobic dimethyl sulfoxide reductase chain B 10.1263.34 2.78
nqrB Na
+-translocating NADH quinone reductase subunit B 4.6261.63 7.65
nqrC Na
+-translocating NADH quinone reductase subunit C 4.5761.3 6.35
nqrE Na
+-translocating NADH quinone reductase subunit E 4.8461.59 6.36
napB Nitrate reductase cytochrome ctype subunit 11.6163.94 4.69
napF Ferredoxin-type protein NapF 15.9465.35 6.42
napD Putative NapD protein 18.5967.25 3.93
apxIVA RTX toxin protein 4.0762.02 1.93
dapA Dihydrodipicolinate synthase 0.0960.02 0.20
leuC 3-isopropylmalate dehydratase large subunit 2 0.1560.14 0.28
ilvH Acetolactate synthase small subunit 0.1360.17 0.27
doi:10.1371/journal.pone.0006139.t002
Gene Expression in BALF
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date. Another Na
+-cycling gene, nhaB (an Na
+/H
+ antiporter),
which, like NQR, could be involved in energy generation or in
sodium homeostasis [46], was also up-regulated in BALF.
In previous studies, the nqrB [23] and nhaB [22] genes and the
NqrA (AopA) protein [50], which are all involved in Na
+-cycling,
have been reported to be up-regulated in A. pleuropneumoniae when
it is grown in vivo. The importance of NQR, the major Na
+-cycling
enzyme, in survival and pathogenesis of A. pleuropneumoniae is
unknown. However, BHI containing 2-n-nonyl-4-hydroxyquino-
line N-oxide (HQNO), an inhibitor of NQR, does not allow
growth of A. pleuropneumoniae CM5, while E. coli DH5a grows well
in media containing HQNO (unpublished data). Further, in
signature tagged mutagenesis studies, the nqrB gene was found to
be essential for persistence A. pleuropneumoniae in the host [51].
Although genome sequencing has revealed that many bacterial
pathogens possess homologues of nqr and other primary and
secondary sodium pumps [46], the role of Na
+ -cycling in
pathogenesis is largely unknown, except in Vibrio cholerae.I nV.
cholerae, mutation of nqr results in increased expression of toxT,a
positive regulator of virulence factors including cholera toxin and
toxin co-regulated pilus [52,53]. NQR is best known for its
involvement in energy transduction, cytoplasmic pH regulation
and ion homeostasis in marine and halophilic bacteria [54,55].
Other BALF-up-regulated A. pleuropneumoniae genes encoding
enzymes of energy metabolism included the heme exporter gene
(ccmC), ATP synthase epsilon chain (atpC), deoxyribosephosphate
aldolase (deoC) and 1-phosphofructokinase (fruK). The ccmC gene is
a part of the ccmABCDEFGH operon which encodes proteins
required for maturation of cytochrome C [56], an essential
component of the electron-transfer chain [57]; whereas AtpC is a
part of the F1 complex of ATP synthase [58]; DeoC cleaves
deoxyribose 5-phosphate to acetaldehyde and glyceraldehyde 3-
phosphate for central carbon metabolism [59]; and FruK regulates
the flow of glucose through glycolysis [60]. Thus in BALF, A.
pleuropneumoniae enhances transcription of the genes encoding both
the central carbon metabolism and the energy transduction
proteins.
The down-regulation of genes encoding TCA cycle related
enzymes, phosphoenolpyruvate carboxylase (pepC and succinyl-
CoA ligase (ADP forming) subunit alpha (sucD) genes (Table S1)
again points to the importance of anaerobic metabolism in A.
pleuropneumoniae. Phophoenolpyruvate carboxylase catalyses car-
boxylation of pyruvate to oxaloacetate and succinyCOA ligase
catalyzes the nucleotide-dependent conversion of succinyl-CoA to
succinate [61,62]. The genes encoding putative haloacid dehalo-
genase like hydrolase (pfhB) and xylose isomerase (xylA) were also
down-regulated, which could be because of the absence of the
substrates for these enzymes in BALF or because alternate
pathways are preferable in that environment. Haloacid dehalo-
genase catalyzes dehalogenation of L-2-haloalkanoic acids to form
D-2-hydroxyalkanoic acids [63] and xylose isomerase converts
xylose to xylulose [64]. The xylose transport system permease gene
(xylH) was also down-regulated in BALF as were the mannitol
(PTS system mannitol-specific EIICBA component, mtlA) and
ribose (D-ribose binding periplasmic protein precursor, rbsB)
transport systems (Table S1) consistent with the absence of
manitol and ribose in BALF or the presence of a preferred
substrate. The ferritin-like protein 2 encoding-gene, ftnB, which is
involved in protection against oxidative damage to iron-sulfur-
containing enzymes such as the tricarboxylic acid (TCA) enzyme
aconitase [65] was also down-regulated in BALF. Since A.
pleuropneumoniae lacks aconitase, the target of FtnB is not obvious.
This result nevertheless suggests that A. pleuropneumoniae is not
under oxidative stress in BALF.
Modulation of gene expression for survival and virulence
in BALF
Following incubation in BALF, A. pleuropneumoniae CM5 up-
regulates genes required for cell wall synthesis, repair and
recombination of DNA, and secretion and trafficking of ions and
biomolecules (Table S1).
Several genes encoding cell wall biosynthesis proteins were up-
regulated in BALF, including those required for synthesis of
peptidoglycan, LPS and integral membrane proteins (Table S1).
Up-regulated genes for peptidoglycan biosynthesis enzymes
included phosphoglucosamine mutase (mrsA), alanine racemase
(alr), and D-alanyl D-alanine carboxypeptidase fraction A (dacA).
MrsA converts glucosamine-6-phosphate to glucosamine-1-pho-
phate which finally yields UDP-N-acetyl glucosamine for both
peptidoglycan and LPS biosynthesis [66–68] while Alr catalyses
the isomerization of L-alanine into D-alanine which is essential in
bacteria for peptidoglycan biosynthesis [66,69], and DacA
catalyzes transpeptidation between neighboring peptide chains of
N-acetylmuramyl-N-acetylglucosyl polysaccharides to produce
cross-links in the cell wall. DacA can also act as a carboxypeptidase
to control the amount of cross-linking in peptidoglycan [70,71].
A semi-rough LPS is present in A. pleuropneumoniae serotype 1
[72], and the BALF-up-regulated genes encoding LPS biosynthesis
proteins included the tetraacyldisaccharide 49kinase (LpxK)
required for lipid-A biosynthesis, and a bifunctional protein
(HldE) and UTPglucose-1-phosphate uridylyltransferase (GalU),
required for LPS core biosynthesis. Genes encoding capsular
Table 3. BALF up-regulated virulence-associated genes reported in other studies.
Genes Type of study Reference no.
bioD1, nhaB, apxIVA, rps, dmsA, hya SCOTS (acute infection; 7 days PI)) [22]
nqrB, dnaG, rpsT, rplL, rho, secA, truD, nusA, atpD, sap, rps, rpl SCOTS (chronic infection; 21 days PI) [23]
dmsA Knockout mutation [25]
nqr, hemA, napB, atp, ccm, recR, tonB, galU, cpxC, gloB Signature tagged mutagenesis (24 h PI) [51]
sec, nusG In vivo expression technology (12 and 16 h PI) [84]
exbB2, atp, dnaK Signature tagged mutagenesis (20 h PI) [85]
apxIVA, malF, malG, APL_0668 (predicted periplasmic lipoprotein
involved in iron transport)
In vivo transcript profiling of A. pleuropneumoniae by
microarray
Deslandes (personal communication)
Complete gene names are given in Table S1.
doi:10.1371/journal.pone.0006139.t003
Gene Expression in BALF
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polysaccharide export inner membrane protein) were also up-
regulated in BALF. While the genes encoding peptidoglycan and
LPS biosynthesis proteins described above are assumed to be
essential for the survival of A. pleuropneumoniae, a clear role for
capsular polysaccharides in the virulence of the bacterium has
been demonstrated [73,74]. In addition to cell surface polysac-
charides synthesis genes, the genes encoding the outer membrane
protein OmpW (outer membrane protein W precursor) and a
lipoprotein (outer membrane antigenic lipoprotein B precursor)
were also up-regulated in BALF. The up-regulation of genes
encoding proteins of cell wall biosynthesis may help the organism
to overcome cell surface-damaging components present in BALF.
Transcription of genes encoding proteins involved in replica-
tion, and recombination and repair was enhanced in BALF. Genes
encoding subunits of DNA polymerase III, various recombination
proteins of the RecF machine, and an exonuclease (uvrA of uvrABC)
were all up-regulated in BALF. Replication and recombination are
two intertwined processes [75]; enhancement of transcription of
genes involved in these two processes is consistent with active
replication of A. pleuropneumoniae in BALF. On the other hand, rec2,
encoding recombination protein2 and involved in transport of
DNA across the cell envelope in competent bacteria [76], was
down-regulated in BALF as were 3 genes predicted to have
transposon functions. The fact that the expression of transposases
is reported to be associated with starvation and other stressful
conditions is again consistent with BALF being a favorable
environment for A. pleuropneumoniae [77].
For survival in the host, bacteria require nutrients for
biosynthesis of various biomolecules. In BALF, A. pleuropneumoniae
increased transcription of genes encoding proteins required for
transport of various nutrients. For example, complex-carbohydrate
transport genes malF and malG, involved in maltose and
maltodextrin transport, were up-regulated in BALF. Similarly,
Group A Streptococcus enhances transcription of genes encoding
proteins required for maltodextrin uptake in saliva and DmalE:-
malT strains are attenuated in their growth and in their ability to
catabolize a-glucans [78]. Genes for amino acid (9) and nucleotide
(3) biosynthesis were down-regulated suggesting that some or all
amino acids and nucleotides were either directly or indirectly,
available in BALF. Consistent with this finding, amino acid
transporters such as BrnQ (for branched chain amino acid) and
SdaC (for serine transport) were up-regulated. In contrast, the
product of the glycerol uptake facilitator gene, glpF, which allows
transport of glycerol, erythritol, pentitols, and hexitol,was down-
regulated, however, this gene is known to be down-regulated
presence of glucose [79].
In BALF, A. pleuropneumoniae also increased transcription of
genes encoding proteins required for transport of iron and
potassium. Genes encoding the cell membrane transport proteins,
ExbD and ExbD2, and FbpB (iron (III) ABC transporter, ATP-
binding protein), which are involved in energy-coupled transport
of the iron-containing compound, transferrin were up-regulated in
BALF, as was fieF. The cation efflux pump, FieF, probably protects
the bacterium from ferrous iron toxicity [80]. The gene encoding
PtsN (PTS system, nitrogen regulatory IIA like protein) was also
up-regulated in BALF. PtsN has recently been shown to regulate
transport of K
+ through its interaction with a K
+ transporter in E.
coli and could be involved in ion homeostasis needed for optimal
survival of A. pleuropneumoniae in BALF [81].
Incubation in BALF also led to increased expression of A.
pleuropneumoniae CM5 genes encoding toxin synthesis and antimi-
crobial-resistance compounds. The ApxIV RTX toxin is reported
to be expressed only in vivo [82,83]. Following exposure to BALF
we have shown in vitro expression of apxIVA for the first time.
ApxIVA is a homolog of FrpC in Neisseria meningitidis. FrpC is
involved in tissue invasion of N. meningitidis [84]. The role, if any, of
ApxIV in the pathogenesis of A. pleuropneumoniae, however, remains
to be demonstrated.
The sapF gene is a part of the sapABCDF operon was up-
regulated in BALF. It is involved in resistance to antimicrobial
peptides in Vibrio fischeri [85], and in non-typable Haemophilus
influenzae [86]. Also, sapD mutants of non-typable H. influenzae have
been shown to be attenuated in a chinchilla model of otitis media
[87]. A. pleuropneumoniae possesses a complete sap operon, which
could have significant role in the survival of the pathogen in the
host. Another detoxification molecule, glyoxylase II (gloB)i sa n
enzyme involved in conversion of dicarbonyl compounds to less
reactive hydroxy acids [88] was also up-regulated. It has been
shown to be essential for survival of A. pleuropneumoniae in vivo [51]
likely by protecting the organism against harmful dicarbonyl
compounds present in the host. Expression of the ostA gene was
also enhanced in A. pleuropneumoniae CM5 after incubation in
BALF. The role for OstA in A. pleuropneumoniae is not known at this
time, but in Helicobacter pylori, OstA confers protection against
organic solvents and antibiotics [89], and in E. coli, it is essential for
survival and has a direct role in membrane biogenesis and effects
the lipid:protein ratio of the cell membrane [90]. In N. meningitidis,
OstA is required for LPS biosynthesis [90].
Transcription of secB, which is a part of the Sec machinery, was
also enhanced in BALF. The Sec machinery plays a key role in the
translocation of proteins across, and integration of some proteins
into, the cytoplasmic membrane of bacteria [91]. In A.
pleuropneumoniae, secA and secB, another protein of the Sec
machinery, have been shown to be expressed in vivo during both
acute and chronic infection [23, 92, and 93].
Several genes encoding transcriptional regulators, protein
stabilization and folding and transposon functions were down-
regulated in BALF. The precise role of these down-regulated
transcriptional regulators is unknown in A. pleuropneumoniae, but
FadR (a member of the GntR family of regulators) is an activator
of unsaturated fatty acid acid synthesis in E. coli, although the
authors do note that the FadR regulon in other gammaproto-
bacteria such as Haemophilus influenzae is much smaller [94].
Nevertheless, it is reasonable to assume that fatty acids would be
freely available in BALF and their synthesis would not be required
[95]. MerR transcriptional regulators have similar N-terminal
helix-turn-helix DNA binding regions and C-terminal effector
binding regions specific to the effector. Most of these regulators
respond to oxidative stress and the presence of heavy metals and
antibiotics in the medium [96]. The down-regulation of a MerR
transcriptional regulator is consistent with the absence of stressors
in the medium.
Similarly, the precise role of protein folding and stabilization
proteins in A. pleuropneumoniae has not been reported, but in other
systems, proteins such as HtpG and HtpX are usually up-regulated
during stress such as nutrient deprivation and their down-
regulation is consistent with BALF being a comparatively non-
stressful environment [97,98].
In the current study, genes encoding 22 ‘‘unclassified or
unknown’’ proteins were up-regulated while genes encoding a
further 19 ‘‘unclassified or unknown’’ proteins were down-
regulated. This large set of gene encoding unknown proteins
could have a significant role in the survival and pathogenesis of A.
pleuropneumoniae. In the future, it may be possible to predict
functions of unknown genes by using bioinformatic approaches
such have been developed for analysis of human microarray data
[99].
Gene Expression in BALF
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conditions and may provide a useful medium for the discovery of
novel vaccine or therapeutic targets. In this environment, A.
pleuropneumoniae is actively involved in protein and cell envelope
biosynthesis and in general, BALF appears to provide a
comparatively favorable and nutrient replete environment.
Although more than 40% of the genes that were up-regulated
following a 30 min exposure to BALF had been reported in earlier
in vivo studies (Table 3), we have described an additional 70 genes
whose precise role in survival and virulence of A. pleuropneumoniae is
unknown and merit further study.
Materials and Methods
Collectin and concentration of bronchoalveolar fluid
(BALF)
BALF was obtained from ten specific pathogen free pigs, each
weighing about 15 kg. The pigs were euthanized, and the lungs
were lavaged in situ using a catheter passed through a
bronchoscope to instill 100 ml of sterile PBS into the trachea.
After ,1 min, lung washings were collected and centrifuged to
remove cell debris. The cell-free lavage was concentrated with a
5 kDa molecular weight cut off ultrafiltration device, Vivacell 70
(Vivascience Ltd., Stonehouse, Gloucestershire,UK). A total of
about 100 ml of BALF was collected from each pig and
concentrated to a final volume of 5 ml. Concentrated BALF from
each pig was pooled and sterilized by passage through a 0.22 mm
membrane filter. From collection to concentration, BALF was kept
at 4uC; the concentrated BALF was stored at 280uC for long-term
storage. Molecules less than 5 kDa in molecular weight were not
concentrated by this method; nevertheless, the fluid still contained
these substances in concentrations found before ultrafiltration and
the concentrated BALF represents alveolar epithelial fluid better
than unprocessed BALF. The procedure used for BALF collection
received approval from the Animal Care Committee of the
University of Guelph and was consistent with the Guidelines of the
Canadian Council on Animal Care.
Assessment of bacterial survival in BALF
Exponential growth phase cultures of A. pleuropneumoniae CM5
and Escherichia coli DH5a were incubated in 2 ml of concentrated
BALF at 37uC. As a control, bacteria were also incubated in
phosphate-buffered saline (PBS). A 50-ml aliquot was taken from
each of the cultures after 15 and 30 min of incubation in BALF
and PBS and plated onto brain heart infusion (BHI; Becton,
Dickinson and Company, Sparks, MD, USA) agar supplemented
with 0.01% (wt/vol) b-nicotinamide adenine dinucleotide (NAD).
The number of colony-forming units (CFU) was counted after
incubation overnight at 37uC. The number of bacteria surviving in
BALF at each time point was expressed as the percent of number
of bacteria surviving in PBS.
The data were analyzed using one-way analysis of variance
(ANOVA); the means were compared using Tukey’s method.
Culture conditions for identification of differentially
expressed genes in BALF
The virulent A. pleuropneumoniae serotype 1 strain CM5 was
grown in BHI (Becton, Dickinson and Company) broth supple-
mented with 0.01% (wt/vol) NAD, at 37uCt oa nO D 600 of 0.7
(approximately 10
7 CFU/ml). The cell suspension was split into
two equal parts and centrifuged at 10,000 xg for 1 min to pellet
the cells. One pellet was suspended in pre-warmed concentrated
BALF and the other in fresh pre-warmed BHI broth supplemented
with NAD. The volume of BALF and BHI broth used to suspend
the cell pellets was equal to that of the culture from which the
pellets were obtained, so that the resulting cell suspension
contained approximately 10
7 CFU/ml. The cell suspensions were
incubated with constant agitation at 37uC for 30 min and
harvested by centrifugation for RNA extraction.
RNA extraction
RNA was extracted using Trizol Reagent (Invitrogen, Carlsbad,
CA, USA) according to the instructions of the manufacturer. RNA
quantity and quality was determined using an RNA 6000 Nano
LabChip read in a Bioanalyzer 2100 instrument (Agilent
Technologies, Santa Clara, CA, USA). RNA was treated with
Turbo DNA-free (Ambion, Austin, TX, USA) to remove traces of
contaminating DNA. For hybridization in microarray experi-
ments, RNA was extracted from 3 independent biological
replicates.
Labeling of cDNA and microarray hybridizations
cDNA synthesis was carried out as described previously [100].
Briefly, RNA (15 mg per reaction) from target (BALF-incubated
bacteria) and reference (BHI-incubated bacteria) samples was used
to synthesize cDNA in the presence of amino-allyl-dUTP (Sigma-
Aldrich, St. Louis MO, US), random octamer primers (Biocorps,
Montreal, QC, Canada), and SuperScript II transcriptase
(Invitrogen, Carlsbad, CA, US). cDNAs were labeled indirectly
with mono-functional NHS-ester Cy3 or Cy5 dye (GE Healthcare,
Buckinghamshire, UK) and the efficiency of the labeling reactions
was determined spectrophotometrically. RNA from three inde-
pendent biological replicates was used in the labeling reaction.
Four hybridizations, including the dye-swap experiment, were
carried out between the target and the reference samples. The
microarray data from this study were submitted to the Gene
Expression Omnibus repository at NCBI and assigned accession
number GEO: GSE13006.
Microarray chip design
The AppChip2 microarray chip used in this study is an evolved
version of the AppChip1 chip, and like its predecessor, was a part of
the A. pleuropneumoniae 5b L20 genome sequencing project [101]. For
construction of AppChip2, open-reading-frame (ORF) PCR
fragments of 160-nucleotide length and above were spotted in
duplicate on microarray slides. The spots represent 2033 ORFs,
covering 95% of the total ORFs, from the complete genome
sequence of the organism. Spotted sheared genomic DNA from A.
pleuropneumoniae L20 and porcine DNA are used as controls (http://
ibs-isb.nrc-cnrc.gc.ca/glycobiology/appchips_e.html). Other de-
tails concerning chip production are described elsewhere [102].
Microarray data analysis
Microarray image and data analysis were carried out using the
TM4 Suite [103] of software. Briefly, images were analyzed with
Spotfinder v3.1.1. Background intensity was subtracted from the
integrated intensity of each spot, and the spots that were less than
one standard deviation above background intensity were elimi-
nated, as were ones with total intensity less than 10,000. Replicate
spots were analyzed subsequent to LOWESS (locally weighted
linear regression) normalization of the data. Genes that were
represented by good quality spots on a minimum of three replicate
slides were considered for downstream analysis using SAM
(significance analysis of microarray) to identify differentially
expressed genes. A median false discovery rate (FDR=expected
rate of falsely identified up- or down-regulated genes [104]) of
1.07% was used to generate a list of differentially expressed genes,
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Comprehensive Microbial Resource [105] tool.
Quantitative real-time PCR
RNA capacity (the maximum RNA concentration that can be
used without affecting efficiency of reverse transcription), optimum
primer concentration (list of primers is given in Table S2), and
gene dynamic ranges were determined before carrying out real-
time PCR for relative quantification of target genes. Synthesis of
template cDNA was carried out in a 20-ml reaction mixture
containing 500 ng RNA, using High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems, Streetsville, ON, Canada).
SYBR-Green-dye-based real-time PCR methodology was carried
out using MicroAmp Optical 96- well plates (Applied Biosystems)
in a StepOnePlus thermocycler (Applied Biosystems) for relative
quantification of target genes. The 20-ml PCR reaction mixtures
contained 10 mlo f2 6 Power SYBR Green PCR Master Mix
(Applied Biosystems), 100 nM of forward and reverse primer, and
5 ml of template cDNA. The real-time PCR thermal profile
included heat-activation of AmpliTaq Gold DNA Polymerase at
95uC for 10 min, and three-step 40-cycle PCR of denaturation at
95uC for 15 sec, primer annealing and extension at 60uC for
1 min.
The Comparative CT (or DD CT) method [106] where DD
CT=(C T, target2CT, syp)BALF2(CT, target2CT, syp)BHI was used to
determine the relative gene expression of the target genes in
BALF. As an endogenous control, the level of prolyl-tRNA-
synthetase gene expression was used to normalize target gene
expression levels, since this gene exhibited the least variation in
expression across various conditions in both the microarray and
real-time PCR experiments. Three independent biological repli-
cates were tested in triplicates in the PCR experiments for the
relative quantification of target genes.
Supporting Information
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Found at: doi:10.1371/journal.pone.0006139.s001 (0.26 MB
DOC)
Table S2
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